Therapeutic potential of targeting IL-17 (Q59632254)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080193%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Therapeutic potential of targeting IL-17 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080193%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080193%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Kingston H Mills

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080193%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Caroline E Sutton

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080193%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Daniel Cua

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080193%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

language of work or name

English

0 references

publication date

1 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080193%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080193%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080193%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080193%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

1022-1025

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080193%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ni.2450

15 February 2020

exact match

0 references

cites work

A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.

1 reference

12 December 2020

Interleukin-17 is a negative regulator of established allergic asthma

1 reference

12 December 2020

Th17 cells in immunity to Candida albicans

1 reference

12 December 2020

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

1 reference

12 December 2020

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

1 reference

12 December 2020

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

1 reference

12 December 2020

Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.

1 reference

12 December 2020

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

1 reference

12 December 2020

Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation

1 reference

12 December 2020

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

1 reference

12 December 2020

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis

1 reference

12 December 2020

Sensing of mammalian IL-17A regulates fungal adaptation and virulence.

1 reference

12 December 2020

Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria.

1 reference

12 December 2020

Laminin-411 is a vascular ligand for MCAM and facilitates TH17 cell entry into the CNS

1 reference

12 December 2020

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

1 reference

12 December 2020

Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumors.

1 reference

12 December 2020

Th17 cells mediate clade-specific, serotype-independent mucosal immunity

1 reference

12 December 2020

Transforming growth factor-beta induces development of the T(H)17 lineage

1 reference

12 December 2020

Association of Interleukin 23 Receptor Variants with Psoriatic Arthritis

1 reference

12 December 2020

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

1 reference

12 December 2020

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

1 reference

12 December 2020

Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis

1 reference

12 December 2020

β-glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice

1 reference

12 December 2020

Control of TH17 cells occurs in the small intestine.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NI.2450

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080193%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

15 February 2020

0 references

1 reference